| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 53.233 | 149.526 | 231.507 | 905.989 | 2.225.934 | 1.975.846 | 2.309.132 | 2.819.747 |
| Total Income - EUR | - | - | 53.233 | 149.526 | 231.518 | 929.908 | 2.227.030 | 1.987.387 | 2.522.702 | 2.897.572 |
| Total Expenses - EUR | - | - | 113.645 | 211.542 | 353.192 | 810.596 | 2.781.004 | 2.508.610 | 3.164.962 | 3.368.575 |
| Gross Profit/Loss - EUR | - | - | -60.412 | -62.017 | -121.674 | 119.312 | -553.974 | -521.223 | -642.261 | -471.004 |
| Net Profit/Loss - EUR | - | - | -60.946 | -63.512 | -123.989 | 110.849 | -558.154 | -521.223 | -642.261 | -471.004 |
| Employees | - | - | 5 | 15 | 21 | 24 | 29 | 29 | 29 | 24 |
Check the financial reports for the company - Ams Laborator Genetic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.459 | 927 | 413 | 271.873 | 246.958 | 217.717 | 202.606 | 105.241 |
| Current Assets | - | - | 11.895 | 286.533 | 243.390 | 520.738 | 778.016 | 729.504 | 703.033 | 464.317 |
| Inventories | - | - | 0 | 0 | 0 | 328.814 | 307.643 | 252.858 | 356.741 | 124.756 |
| Receivables | - | - | 11.304 | 285.720 | 242.355 | 90.930 | 308.599 | 382.193 | 317.510 | 304.472 |
| Cash | - | - | 591 | 813 | 1.036 | 100.994 | 161.774 | 94.453 | 28.783 | 35.090 |
| Shareholders Funds | - | - | -60.727 | -123.124 | -244.729 | -129.240 | -684.528 | -1.207.875 | -1.846.473 | -2.307.157 |
| Social Capital | - | - | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | 74.789 | 411.389 | 489.381 | 921.851 | 1.735.986 | 2.175.531 | 2.784.605 | 2.876.716 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ams Laborator Genetic Srl